Avid Bioservices Inc (CDMO)

[entdoc]

Maybe Wednesday announcement has nothing to do with Avid or Bavi, as CJGaddy wrote in 2008 re patent portfolio: "Peregrine has exclusively licensed Dr. Philip Thorpe & Dr. Rolf Brekken’s VTA & APT (Anti-Phospholipid Therapy) discoveries thru a sponsored research collaboration with UTSW/Dallas, and has in-licensed “Anti-PS Methods” and B2GP1/Anti-Angiogenesis from M.D.Anderson/Houston (Dr. Alan Schroit). These technologies include Anti-Phospholipid Therapy agents (3G4/Bavituximab, other Anti-PS mabs, Anti-PE…) which provide a ‘unique approach to treating both cancers and viral diseases’, the Anti-Angiogenesis agent 2C3, and other VTAs (like Anti-PSMA & Anti-Fibronectin). Most recently (7-2007), Peregrine has in-licensed “certain Anti-PS antibodies” from The Univ. of California, possibly including Anti-PS mabs like ‘IS1’ & ‘CL1’ from UCLA (Dr. Pojen P. Chen). In 1994 & 2004, Peregrine licensed the TNT & VEA technology (Dr. Alan Epstein’s discoveries) from USC and Cancer Biologics, Inc. Maybe news from Russia or China? Good luck to all!